Alan Moses was educated at Duke University (BS) and Washington University School of Medicine (MD) prior to training at Barnes Hospital in St. Louis, MO, the National Institutes of Health in Bethesda, MD, and Tufts-New England Medical Center in Boston. Dr. Moses is board certified by the ABIM with subspecialty certification in Endocrinology and Metabolism. He is a Fellow of the American College of Physicians. His academic career focused on basic and translational research at Harvard Medical School where he was a Professor of Medicine. He served as Senior Vice President and Chief Medical Officer of the Joslin Diabetes Center. Dr. Moses joined Novo Nordisk in 2004 and became Global Chief Medical Officer in 2008. As Global CMO, he was involved in the full spectrum of the diabetes focus of Novo Nordisk from drug discovery, through drug development, brand messaging, and the implications of diabetes for the company and for patients, healthcare professionals and for healthcare systems. He retired from Novo Nordisk in June 2018 to pursue independent consulting and joined the Board of Directors of diaTribe Foundation in 2018.